Beijing Bia United Drug Research Institute

Beijing Bia United Drug Research Institute is a Chinese pharmaceutical research organization specializing in the development of Traditional Chinese Medicine (TCM) and natural health products. The institute is primarily recognized for its focus on metabolic health, particularly in creating proprietary formulations for the management of type 2 diabetes and cardiovascular conditions. Its flagship product line, marketed under the Bia United and Bo'ai brands, includes the well-known Tang-An-Kang supplement for blood glucose regulation. The organization integrates traditional herbal knowledge with modern pharmacological research to produce standardized therapeutic products. While its primary operations are within the Chinese domestic market, the institute's products have also reached international consumers through export channels. It remains a significant entity in the field of evidence-based herbal medicine in China.